Preprint · OA
via OpenAlex
Alpha‐synuclein and familial Parkinson's disease
Nathan Pankratz, William C. Nichols, Veronika E. Elsaesser, Michael W. Pauciulo, Diane K. Marek, Cheryl A. Halter, Joanne Wojcieszek, Alice Rudolph, Ronald F. Pfeiffer, Tatiana Foroud, for the Parkinson Study Group – PROGENI Investigators
Movement Disorders · 2009 · ▲ 45 citations
Abstract
Whole gene duplications and triplications of alpha-synuclein (SNCA) can cause Parkinson's disease (PD), and variation in the promoter region (Rep1) and 3' region of SNCA has been reported to increase disease susceptibility. Within our cohort, one affected individual from each of 92 multiplex PD families showing the greatest evidence of linkage to the region around SNCA was screened for dosage alterations and sequence changes; no dosage or non-synonymous sequence changes were found. In addition, 737 individuals (from 450 multiplex PD families) that met strict diagnostic criteria for PD and did not harbor a known causative mutation, as well as 359 neurologically normal controls, were genotyped for the Rep1 polymorphism and four SNPs in the 3' region of SNCA. The four SNPs were in high LD (r(2) > 0.95) and were analyzed as a haplotype. The effects of the Rep1 genotype and the 3' haplotype were evaluated using regression models employing only one individual per family. Cases had a 3% higher frequency of the Rep1 263 bp allele compared with controls (OR = 1.54; empirical P-value = 0.02). There was an inverse linear relationship between the number of 263 bp alleles and age of onset (empirical P-value = 0.0004). The 3' haplotype was also associated with disease (OR = 1.29; empirical P-value = 0.01), but not age of onset (P = 0.40). These data suggest that dosage and sequence changes are a rare cause of PD, but variation in the promoter and 3' region of SNCA convey an increased risk for PD.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1002/mds.22524
- Canonical
- link ↗
- Fetched
- 2026-10-20 MST
Cite this
APA
Pankratz, N., Nichols, W.C., Elsaesser, V.E., Pauciulo, M.W., Marek, D.K., Halter, C.A., Wojcieszek, J., Rudolph, A., Pfeiffer, R.F., Foroud, T., & Investigators, F.T.P.S.G.�.P. (2009). Alpha‐synuclein and familial Parkinson's disease. <em>Movement Disorders</em>. https://doi.org/10.1002/mds.22524
Vancouver
Pankratz N, Nichols WC, Elsaesser VE, Pauciulo MW, Marek DK, Halter CA, et al. Alpha‐synuclein and familial Parkinson's disease. Movement Disorders. 2009. doi:10.1002/mds.22524.
BibTeX
@unpublished{nathan2009Alphas,
title = {Alpha‐synuclein and familial Parkinson's disease},
author = {Nathan Pankratz and William C. Nichols and Veronika E. Elsaesser and Michael W. Pauciulo and Diane K. Marek and Cheryl A. Halter and Joanne Wojcieszek and Alice Rudolph and Ronald F. Pfeiffer and Tatiana Foroud and for the Parkinson Study Group – PROGENI Investigators},
journal = {Movement Disorders},
year = {2009},
doi = {10.1002/mds.22524},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
The Lancet 2004
Citation only
α-synuclein locus duplication as a cause of familial Parkinson's disease
Neurology 2008
Citation only
α-Synuclein, pesticides, and Parkinson disease
Movement Disorders 2009
Citation only
Alpha‐synuclein polymorphisms are associated with Parkinson's disease in a Saskatchewan population
JAMA 2006
Preprint · CC-BY
Collaborative Analysis of α-Synuclein Gene Promoter Variability and Parkinson Disease
Neurology 1998
Citation only
Failure to find the a‐synuclein gene missense mutation (G 209 A) in 100 patients with younger onset Parkinson's disease
Movement Disorders 2019
Open access · OA